Biotage AB (Biotage AB) Net Margin %

: 20.37% (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Biotage AB's Net Income for the three months ended in Dec. 2023 was $12.8 Mil. Biotage AB's Revenue for the three months ended in Dec. 2023 was $62.7 Mil. Therefore, Biotage AB's net margin for the quarter that ended in Dec. 2023 was 20.37%.

The historical rank and industry rank for Biotage AB's Net Margin % or its related term are showing as below:

BITGF' s Net Margin % Range Over the Past 10 Years
Min: 12 Med: 16.34 Max: 18.55
Current: 13.21

BITGF's Net Margin % is ranked better than
78.97% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 0.045 vs BITGF: 13.21

Biotage AB Net Margin % Historical Data

The historical data trend for Biotage AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

16.96

16.03

16.64

17.11

13.21

Biotage AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %																19.27	11.91	8.31	8.46	20.37

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Biotage AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotage AB Net Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where Biotage AB's Net Margin % falls into.

Biotage AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Biotage AB's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	23.982	/	181.524
	=	13.21 %

Biotage AB's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	12.771	/	62.685
	=	20.37 %

Biotage AB (OTCPK:BITGF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Biotage AB Net Margin % Related Terms

Thank you for viewing the detailed overview of Biotage AB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (Biotage AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.